, end of June 30, 2020 Financial Statement Consolidate financial statement % Revenue from sales Q1/2020 Q1/2019 increase (decrease) Q1/2020 Q1/2019 Revenue from sales 85.68 121.53 (35.85) (29.50%) 100.00

Public Company Limited (“the Company”) would like to submit the Management Discussion and Analysis for the second quarter ended June 30, 2020 as follows: Revenue from Sales For the first 6 months of 2020

months, end of March 31, 2020 Financial Statement Consolidate financial statement % Revenue from sales Q1/2020 Q1/2019 Increase (decrease) Q1/2020 Q1/2019 Revenue from sales 45.46 67.47 (22.01 ) (32.62

: million Baht) For 9 months, end of September 30, 2020 Financial Statement Consolidate financial statement % Revenue from sales Q3/2020 Q3/2019 increase(decrease) Q3/2020 Q3/2019 Revenue from sales 117.39

Unit: Million Baht million baht % million baht % million baht % Revenue from sales of real estate 238.90 98.68 238.90 98.39 169.60 97.98 69.30 40.86 Other income 3.19 1.32 3.92 1.61 3.49 2.02 0.43 12.32

June 2020 Unit: THB Million Q2/2020 Q1/2020 QoQ Q2/2019 YoY 6M2020 6M2019 YoY Total Revenue 26,594 43,070 -38% 48,326 -45% 69,665 93,861 -26% Accounting EBITDA 1,131 (2,546) 144% 2,189 -48% (1,415) 4,147

cannot generate revenue immediately; some investments are not fully utilized or have not reached an optimal level yet; and some projects are delayed. Thus, costs per unit climbed up at this point; 4

Summary Significant Event Operating Highlights in Q3/2023 Q3/22 Q3/23 Change +/(-) 9M/22 9M/23 Change +/(-) (THB million) %YoY %YoY Operating Revenue 246 338 37% 674 900 34% Gross Profit 159 223 40% 426 583

Company and its subsidiary for the fiscal year ended on 31 December 2019 as follows; Statements of Comprehensive Income Revenue from medical treatment The Company generated the revenue from medical

the follow main reasons. 1. Revenue from hospital operations increased by Baht 102.22 million or 4.52 % due to in 2018 the general patients of Company and subsidiaries increased. 2. Cost of hospital